About this event
See the brightest in New England HealthTech — and hear investors rate their pitches.
Five entrepreneurs in the health security space will face tough questions from a panel of respected life sciences investors and influencers in this annual "Shark Tank"-style pitch event. Emcee: Kenn Turner, President/CEO of Massachusetts Life Sciences Center.
Join us IN PERSON October 3 at Mintz in Boston:
In-person events are back — and that means in-person networking. Seize this opportunity to make new connections over refreshments and apps.
(Walk-ins welcome with proof of COVID vaccination.)
Before the pitches, a provocative panel discussion: "Preparing for the Unimaginable"
What have we learned from COVID? What are the gaps in our health security readiness and how can we close them? A panel of Boston experts will share and debate their insights as they refer to the report from the White House “Progress Towards Implementation of The American Pandemic Preparedness Plan.”
Learn more about our panelists:
- Matt Hepburn
- Kenn Turner
- Chiara Ghezzi
- David McManus
- Stefan Riedel
- Wiljeana Glover
You could win a pair of AirPods®!
One lucky attendee will win this year’s raffle, a pair of M2D2-branded AirPods! You must register and attend to be eligible for this raffle.
Meet the startups pitching their health security solutions.
Versatope Therapeutics – Delivering immunity with a transformational biotechnology platform
bTECH – Patent-pending Halcyon SMART Patch (HSP) uses far infrared wavelengths beneath the surface of the skin to promote rapid tissue healing and strengthening.
Innotech Precision Medicine – Revolutionizing the in vitro diagnostics (IVD) industry by allowing for better, faster, and more cost-effective detection of multiple classes of disease biomarkers in one test.
Genomic Expression – Developing an RNA platform for Next Generation Cures to better detect disease, monitor health, and design the Next Generation Cures.
Partner Therapeutics - An integrated, commercial-stage biopharmaceutical company focused on development and commercialization of novel therapies to treat diseases with significant unmet need.
